Advertisement
Advertisement

ANRO

ANRO logo

Alto Neuroscience Inc.

15.44
USD
Sponsored
+0.12
+0.75%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

15.46

+0.03
+0.19%

ANRO Earnings Reports

Positive Surprise Ratio

ANRO beat 5 of 8 last estimates.

63%

Next Report

Date of Next Report
Mar 20, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.54
Implied change from Q3 25 (Revenue/ EPS)
--
/
+3.85%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-3.57%

Alto Neuroscience Inc. earnings per share and revenue

On Nov 12, 2025, ANRO reported earnings of -0.52 USD per share (EPS) for Q3 25, beating the estimate of -0.68 USD, resulting in a 23.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.97% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -0.54 USD, with revenue projected to reach -- USD, implying an increase of 3.85% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Alto Neuroscience Inc. reported EPS of -$0.52, beating estimates by 23.65%, and revenue of $0.00, 0% as expectations.
The stock price moved up 5.97%, changed from $13.40 before the earnings release to $14.20 the day after.
The next earning report is scheduled for Mar 20, 2026.
Based on 12 analysts, Alto Neuroscience Inc. is expected to report EPS of -$0.54 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement